HomeXBIO • NASDAQ
Xenetic Biosciences Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 648.82K | -3.44% |
Operating expense | 1.75M | -9.32% |
Net income | -1.05M | 9.99% |
Net profit margin | -162.53 | 6.77% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.17M | -31.36% |
Total assets | 6.90M | -34.92% |
Total liabilities | 894.26K | 10.46% |
Total equity | 6.01M | — |
Shares outstanding | 1.54M | — |
Price to book | 0.67 | — |
Return on assets | -36.77% | — |
Return on capital | -42.13% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.05M | 9.99% |
Cash from operations | -673.99K | 15.01% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -673.99K | 15.01% |
Free cash flow | -1.01M | -994.11% |
Previous close
$2.60
Day range
$2.47 - $2.53
Year range
$2.26 - $5.18
Market cap
3.80M USD
Avg Volume
6.50K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1997
Headquarters
Website
Employees
2
